Janux Therapeutics

United States
San Diego, California, United States, 92037

Company profile

Janux Therapeutics company profile

Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.

Business identity

Phone number
858-751-4493
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$898.9M
Last funding
Post IPO Equity / $350M / 2024-12-03
Last equity funding
Post IPO Equity / $350M
Investors
12
Lead investors
2
Founders
1
Articles
194
Exited on
2021-06-11

Founders and investors

Founders

David Campbell

Lead investors

Avalon VenturesRA Capital Management

Investors

Correlation VenturesJanus Henderson InvestorsOrbiMedRA Capital ManagementSamsara BioCapital